Personalized prediction for a 64 year old man who takes Amlodipine, Aspirin, Valsartan (an AI-powered real world drug study)
Summary:
This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.
On Sep, 11, 2025, 3,832,061 related reports were analyzed:
What are the drugs?
- Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,717 Amlodipine users. Check the latest studies of Amlodipine.
- Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,002 Aspirin users. Check the latest studies of Aspirin.
- Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,785 Valsartan users. Check the latest studies of Valsartan.
What are the conditions?
- Heart attack is found to be associated with 2,572 drugs and 3,255 conditions by eHealthMe. Check the latest studies of Heart attack.
- Heart health: no further information found.
- Thin blood is found to be associated with 3,844 drugs and 4,838 conditions by eHealthMe. Check the latest studies of Thin blood.
What are the symtoms?
- Heart health: no further information found.
Potential side effects:
- 6.63% for males aged 64 (±5) who have heart health and thin blood
- 6.45% for males aged 64 (±5) who have heart health and heart attack
- 5.16% for males aged 64 (±5) who have thin blood and heart attack
- 5.86% for males aged 64 (±5) who have heart health and thin blood
- 7.89% for males aged 64 (±5) who have heart health and heart attack
- 6.78% for males aged 64 (±5) who have thin blood and heart attack
- 5.97% for males aged 64 (±5) who have heart health and thin blood
- 5.64% for males aged 64 (±5) who have heart health and thin blood
- 5.3% for males aged 64 (±5) who have heart health and thin blood
- 10.87% for males aged 64 (±5) who have heart health and heart attack
- 8.68% for males aged 64 (±5) who have thin blood and heart attack
- 5.15% for males aged 64 (±5) who have heart health and heart attack
- 6.3% for males aged 64 (±5) who have heart health and thin blood
- 19.45% for males aged 64 (±5) who have heart health and thin blood
- 6.47% for males aged 64 (±5) who have thin blood and heart attack
Potential co-existing conditions:
- 10.61% for males aged 64 (±5) who have heart health and thin blood
- 8.62% for males aged 64 (±5) who have heart health and thin blood
- 8.66% for males aged 64 (±5) who have heart health and heart attack
- 7.7% for males aged 64 (±5) who have thin blood and heart attack
- 5.64% for males aged 64 (±5) who have heart health and thin blood
- 13.34% for males aged 64 (±5) who have heart health and heart attack
- 10.89% for males aged 64 (±5) who have thin blood and heart attack
- 6.74% for males aged 64 (±5) who have heart health and thin blood
- 8.73% for males aged 64 (±5) who have heart health and thin blood
- 6.3% for males aged 64 (±5) who have heart health and thin blood
- 6.41% for males aged 64 (±5) who have heart health and thin blood
- 7.99% for males aged 64 (±5) who have heart health and heart attack
- 6.14% for males aged 64 (±5) who have thin blood and heart attack
- 100.0% for males aged 64 (±5) who have heart health and thin blood
- 23.24% for males aged 64 (±5) who have thin blood and heart attack
- 5.08% for males aged 64 (±5) who have heart health and heart attack
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
Related publications that referenced our studies
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pletal cause Consciousness - Decreased? - 3 seconds ago
- Lidoderm vs. Oxytocin 5 Usp Units In Dextrose 5%, side effect and effectiveness comparison - 19 seconds ago
- Erythromycin vs. Clindamycin Phosphate In Dextrose 5%, side effect and effectiveness comparison - 36 seconds ago
- Drug interactions of Cytosar-U and Meropenem - 46 seconds ago
- Could Triazolam cause Idiopathic Pulmonary Fibrosis? - 50 seconds ago
- Could Adalat Cc cause Skin Discoloration? - 59 seconds ago
- Methylin Er vs. Xanax, side effect and effectiveness comparison - a minute ago
- Drug interactions of Pantoprazole Sodium and Tasigna - a minute ago
- Could Famotidine cause Oral Mucosa Erosion? - a minute ago
- Could Prilosec cause Vulvovaginal Discomfort? - a minute ago
Recent personalized studies on eHealthMe:
- Prediction of Amlodipine, Valsartan, Aspirin for a 64 year old man - 23 minutes ago
- A study for a 61 year old woman who takes Atorvastatin Calcium - 4 hours ago
- A study for a 54 year old man who takes Ziprasidone Hydrochloride - 6 hours ago
- Drug comparison of Indocin, Coq10, Vitamin D3 for a 65 year old man - 9 hours ago
- A study for a 80 year old man who takes Bayer Low Dose Aspirin (81mg Aspirin), Sertraline Hydrochloride, Atorvastatin Calcium, Hydrochlorothiazide, Ezetimibe - 14 hours ago
- Prediction of Entresto, Atorvastatin Calcium, Alfuzosin Hydrochloride, Trelegy Ellipta, Finasteride, Ofev for a 77 year old man - 20 hours ago
- A study for a 46 year old woman who takes Ivermectin, Pravastatin Sodium, Lisinopril, Pristiq - 21 hours ago
- Prediction of Irbesartan for a 69 year old woman - 23 hours ago
- Drug comparison of Nitrofurantoin, Phentermine for a 75 year old woman - 23 hours ago
- Drug comparison of Ramipril, Clopidogrel for a 82 year old woman - a day ago